Fottner, C.; Rossmann, H.; Bickmann, J. K. et al.
Definition of a new algorithm for molecular-genetic testing of patients with hereditary pheochromocytoma and paraganglioma syndromesEXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. Bd. 121. H. 3. 2013
Deterding, Katja; Gruner, Norbert; Buggisch, Peter et al.
Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trialLANCET INFECTIOUS DISEASES. Bd. 13. H. 6. 2013 S. 497-506
Lukacs-Kornek, Veronika; Schuppan, Detlef
Dendritic cells in liver injury and fibrosis: Shortcomings and promisesJOURNAL OF HEPATOLOGY. Bd. 59. H. 5. 2013 S. 1124-1126
Liu, Jimmy Z.; Hov, Johannes Roksund; Folseraas, Trine et al.
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitisNATURE GENETICS. Bd. 45. H. 6. 2013 S. 670-+
Rusai, K.; Prokai, A.; Juanxing, C. et al.
Dexamethasone protects from renal ischemia/reperfusion injury: A possible association with SGK-1ACTA PHYSIOLOGICA HUNGARICA. Bd. 100. H. 2. 2013 S. 173-185
Heeren, J.; Gamstaetter, T.; Koch, S. et al.
Diabetes mellitus is a predictor of longer overall survival in patients with Hepatitis-C virus-induced hepatocellular carcinoma with or without curative therapy.INTERNIST. Bd. 54. 2013 S. 86-86
Kohl, Tobias; Gehrke, Nadine; Schad, Arno et al.
Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cellsCell death & disease. Bd. 2013. H. 4. London: Nature Publishing Group 2013 e712
Greten, T. F.; Malek, N. P.; Schmidt, S. et al.
Diagnosis of and Therapy for Hepatocellular CarcinomaZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 51. H. 11. 2013 S. 1269-1326
Jenssen, C.; Barreiros, A.; Hocke, M. et al.
Diagnostic Endosonography 2013-Proven, Problems and NoveltiesENDOSKOPIE HEUTE. Bd. 26. H. 1. 2013 S. 13-29
Weng, Shih-Yen; Padberg, Kornelius; Kim, Yong Ook et al.
Differential regulation of liver fibrosis progression and regression by pharmacological inhibition of M2 macrophage polarization through IL-4Ralpha1HEPATOLOGY. Bd. 58. 2013 S. 577A-577A